Trazodone Drug Interactions to Review by Name

Build a complete interaction list

Interaction categories in the label

MAOIs create the clearest contraindication

DailyMed contraindicates trazodone during treatment with MAOIs and within the stated separation period because of serotonin-syndrome risk. Coordination matters in both directions when switching. The patient should not calculate the interval alone or restart an old prescription while another clinician is using linezolid or intravenous methylene blue.

Other serotonergic medicines can add risk

SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan and St. John’s wort are examples named in prescribing information. The presence of one does not create a universal internet answer. The clinician evaluates purpose, dose, alternatives and how symptoms will be monitored.

QT-prolonging combinations need heart context

The label advises avoiding trazodone with other medicines known to prolong QT. The risk discussion also uses personal and family rhythm history, fainting, recent heart attack and other factors. A pharmacy interaction alert is a prompt for clinical review, not a reason to ignore the medicine or stop it independently. For more detail on this decision, review trazodone safety.

Bleeding risk often hides in nonprescription products

Aspirin and NSAIDs such as ibuprofen or naproxen may be taken without appearing on the prescription list. Antiplatelet medicines and anticoagulants also matter. The patient should report frequency and reason, not only the product name, and seek help for serious bleeding signs.

CNS depressants can compound impairment

Alcohol, barbiturates and other central nervous system depressants can add to sedation and impaired judgment. Sleep aids, pain medicines and anxiety medicines may be relevant even when used only occasionally. The clinician needs the real pattern of use to discuss driving, falls and other safety-sensitive activities.

CYP3A4 modifiers can alter exposure

Strong CYP3A4 inhibitors or inducers can affect trazodone levels, and the label gives clinicians adjustment considerations. This is not a self-dosing instruction. Antibiotics, antifungals, seizure medicines, HIV treatments and other products should be named exactly so the prescriber and pharmacist can determine whether the pathway changes. A related clinical question is covered in trazodone dosage.

One pharmacy profile helps, but it is not complete by itself

A dispensing pharmacy may see many prescriptions but not supplements, samples, cash purchases, another pharmacy’s medicines or substances. Bring a reconciled list to every relevant clinician and update it when something changes. Ask the pharmacist to explain alerts in plain language rather than dismissing or catastrophizing them.

Multiple prescribers need the same medication truth

Mental-health, primary-care, emergency, dental and specialty clinicians may each see only part of the list. Carry one current record and identify the dispensing pharmacies. When a new product is proposed, ask who will coordinate the final decision and monitoring. This prevents an interaction alert from becoming everyone’s concern but no one’s responsibility.

Pharmacy alerts need explanation rather than dismissal

An automated alert may be clinically important, manageable with monitoring or irrelevant to the exact situation. Ask the pharmacist what combination triggered it and what action is recommended. Then make sure the prescriber sees the same information. Neither ignoring every alert nor stopping every flagged medicine produces a safe medication plan.